Fukushima, Akira
Maruko, Ichiro https://orcid.org/0000-0001-5647-6372
Chujo, Kyoko
Hasegawa, Taiji
Arakawa, Hisaya
Iida, Tomohiro
Funding for this research was provided by:
JSPS KAKENHI (JP 20K09781)
Article History
Received: 30 October 2020
Revised: 11 February 2021
Accepted: 13 February 2021
First Online: 2 March 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board of the Tokyo Women’s Medical University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Dr. Fukushima has nothing to disclose. Dr. Maruko reports grants from JSPS KAKENHI (Grant Number JP 20K09781), grants and personal fees from Alcon Pharma K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., and personal fees from NIDEK Co., Ltd., outside the submitted work. Dr. Chujo has nothing to disclose. Dr. Hasegawa has nothing to disclose. Dr. Arakawa has nothing to disclose. Dr. Iida reports grants and personal fees from Alcon Pharma K.K. (Japan), personal fees from Bayer Yakuhin, Ltd. (Japan), grants and personal fees from Santen Pharmaceutical Co., Ltd. (japan), grants from Nidek (Japan), grants from Senju Seiyaku (Japan), research support from Canon (Japan), research support from Kowa (Japan), and research support from Topcon (Japan), outside the submitted work.